Treatment Patterns and Outcomes Before and After Human Regular U-500 Insulin Initiation via Kwikpen in US Veterans with Type 2 Diabetes

被引：0
|
作者：
Chen, Jieling
Fan, Ludi
Juneja, Rattan
Borra, Sujana
Huang, Ahong
Wang, Li
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-134-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
134-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Initiation of human regular U-500 insulin use is associated with improved glycemic control: a real-world US cohort study
    Eby, Elizabeth L.
    Curtis, Bradley H.
    Gelwicks, Steven C.
    Hood, Robert C.
    Idris, Iskandar
    Peters, Anne L.
    Bergenstal, Richard M.
    Jackson, Jeffrey A.
    BMJ OPEN DIABETES RESEARCH & CARE, 2015, 3 (01):
  • [22] Practice Tips and Tools for the Successful Use of U-500 Regular Human Insulin The Diabetes Educator Is Key
    Cochran, Elaine K.
    Valentine, Virginia
    Samaan, Karen H.
    Corey, Ilene B.
    Jackson, Jeffrey A.
    DIABETES EDUCATOR, 2014, 40 (02): : 153 - 165
  • [23] Combination Use of U-500 Regular Insulin via Insulin Pump and Rapid-Acting U-100 Prandial Injections for Treatment of Pre-Existing Type 2 Diabetes in Pregnancy
    Szmuilowicz, Emily D.
    Aleppo, Grazia
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (07) : 525 - 530
  • [24] OPTIMIZED HUMAN REGULAR U-500 INSULIN TREATMENT IMPROVES β-CELL FUNCTION IN SEVERELY INSULIN-RESISTANT PATIENTS WITH LONG-STANDING TYPE 2 DIABETES AND HIGH INSULIN REQUIREMENTS
    Mari, Andrea
    Rosenstock, Julio
    Ma, Xiaosu
    Li, Ying G.
    Jackson, Jeffrey A.
    ENDOCRINE PRACTICE, 2015, 21 (12) : 1344 - 1352
  • [25] Human Regular U-500 Insulin Use Is Associated With Improved Glycemic Control: A Naturalistic US Cohort Study
    Eby, Elizabeth
    Wang, Ping
    Curtis, Brad
    Haldane, Diane
    Idris, Iskandar
    Peters, Anne
    Bergenstal, Richard
    Hood, Robert
    Jackson, Jeffrey A.
    DIABETES, 2013, 62 : A649 - A649
  • [26] Extreme Insulin Resistance: Indications and Approaches to the Use of U-500 Insulin in Type 2 Diabetes Mellitus
    Alexandria M. Dailey
    Lisa R. Tannock
    Current Diabetes Reports, 2011, 11 : 77 - 82
  • [27] Case Series of U-500 Insulin Use in Adults With Type 2 Diabetes and Severe Insulin Resistance
    Zamora, Jacob M.
    Kong, Jason M.
    CANADIAN JOURNAL OF DIABETES, 2021, 45 (01) : 55 - 58
  • [28] The Effect of Liraglutide Added to U-500 Insulin in Patients with Type 2 Diabetes and High Insulin Requirements
    Lane, Wendy
    Weinrib, Stephen
    Rappaport, Jonathan
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (05) : 592 - 595
  • [29] Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements
    Ma, Xiaosu
    Benson, Charles T.
    Prescilla, Randy
    Zhang, Shuyu
    Linnebjerg, Helle
    LaBell, Elizabeth S.
    Morrow, Linda A.
    Jackson, Jeffrey A.
    Nguyen, Alex
    Ilag, Liza L.
    Johnson, Jennal L.
    Leishman, Derek
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (02): : 401 - 407
  • [30] Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin (U-500R) Administered via Continuous Subcutaneous Insulin Infusion (CSII) vs. Subcutaneous Injection (SCI) in Adults with Type 2 Diabetes and High Insulin Requirements
    Ma, Xiaosu
    Prescilla, Randy P.
    Zhang, Shuyu
    Linnebjerg, Helle
    Morrow, Linda
    Jackson, Jeffrey A.
    Johnson, Jennal
    Leishman, Derek
    DIABETES, 2018, 67
12345